Live attenuated-nonpathogenic Leishmania and DNA structures as promising vaccine platforms against leishmaniasis: innovations can make waves
Leishmaniasis is a vector-borne disease caused by the protozoan parasite of Leishmania genus and is a complex disease affecting mostly tropical regions of the world. Unfortunately, despite the extensive effort made, there is no vaccine available for human use. Undoubtedly, a comprehensive understand...
Main Authors: | Negar Seyed, Tahereh Taheri, Sima Rafati |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-04-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2024.1326369/full |
Similar Items
-
Live vaccination tactics: possible approaches for controlling visceral leishmaniasis
by: Noushin eSaljoughian, et al.
Published: (2014-03-01) -
Leishmania tarentolae as Potential Live Vaccine Co-Expressing Distinct Salivary Gland Proteins Against Experimental Cutaneous Leishmaniasis in BALB/c Mice Model
by: Mahya Sadat Lajevardi, et al.
Published: (2022-06-01) -
Expressional Comparison Between Episomal and Stable Transfection of a Selected tri-fusion Protein in Leishmania tarentolae
by: Tahereh Taheri, et al.
Published: (2014-08-01) -
The History of Live Attenuated <i>Centrin</i> Gene-Deleted <i>Leishmania</i> Vaccine Candidates
by: Greta Volpedo, et al.
Published: (2022-04-01) -
DNA-Based Vaccine Is More Efficient than Non-Pathogenic Live Vaccine for the Prevention of HPV16 E7-Overexpressing Cancers
by: Amin Daemi, et al.
Published: (2014-08-01)